News for InspireMD, Inc. (NSPR-WT)

InspireMD (NSPR) will release its first quarter 2025 financial results on May 9, 2025. The company will host a conference call and webcast at 8:30 a.m.

MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Prime carotid stent system for the treatment of carotid artery d

Revenue (Q4 2024): $1.95 million, a 10.6% increase year-over-year.Full Year Revenue (2024): $7 million, a 13% increase from 2023.Gross Profit (Q4 2024): $469,0

Mar 12, 2025 / 12:30PM GMTOperator Please standby. Your program is about to begin. (Operator Instructions) Hello, and welcome to InspireMD's fourth-quarter 2024

NSPR (NASDAQ:NSPR) Q4 2024 Earnings Conference Call March 12, 2025 8:30 AM ETCompany ParticipantsMarvin Slosman - CEOCraig Shore - CFOShane Gleason -...

InspireMD (NSPR) delivered earnings and revenue surprises of 5% and 6.50%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

**media[564212]**

MIAMI, Feb. 26, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Prime carotid stent system for the treatment of carotid artery di

**media[549752]**

MIAMI, Feb. 25, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Prime carotid stent system for the prevention of stroke, today an

On December 31, 2024, Nantahala Capital Management, LLC (Trades, Portfolio) made a significant move by increasing its stake in InspireMD Inc (NSPR). The firm ad

TOLEDO, Ohio and MIAMI, Feb. 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Prime Carotid Stent System for the prevention of

On December 31, 2024, Rosalind Advisors, Inc. (Trades, Portfolio) significantly increased its investment in InspireMD Inc. by acquiring an additional 7,419,918

**media[531558]**

MIAMI, Jan. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Prime carotid stent system for the prevention of stroke, today an

InspireMD CFO Craig Shore to retire, successor search underway

MIAMI, Dec. 12, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. ( NSPR), developer of the CGuardâ„¢ Embolic Prevention Stent System (EPS) for the prevention of strok

**media[487010]**

Study represents a significant step forward in Company's mission to serve the broadest set of physician and patient needs with best-in-class CAS and TCAR solut